Medscape Conference Coverage, based on selected sessions at the:

XVII European Stroke Conference

May 13 - 16, 2008; Nice, France

This activity is not sanctioned by, nor a part of, the European Stroke Conference. Conference news does not receive grant support and is produced independently.

Conference News

Largest-Ever European Stroke Research Initiative Launched

In the largest European stroke research program ever undertaken, countries in the European Union are joining forces in a unique effort to structure, integrate, and advance stroke research.
Medscape Medical News, May 27, 2008
Higher Carotid Restenosis Rates

Patients with severe symptomatic carotid stenosis treated with endovascular therapy appear to have higher rates of restenosis than their counterparts treated with carotid endarterectomy. However, the higher restenosis rate is limited to those treated with angioplasty and does not include endovascular treatment with the use of stents.
Medscape Medical News, May 26, 2008
AVERT: Very Early Exercise Safe Following Acute Stroke

Getting stroke patients out of bed and engaging in early intensive exercise therapy within 24 hours of symptom onset is a safe method of rehabilitation -- even among patients who been treated with tPA.
Medscape Medical News, May 23, 2008
Antiplatelet, Lipid-Lowering Therapy Linked With Absence of Embolic Signals

An association between the absence of baseline transcranial Doppler embolic signals and antiplatelet and statin therapy exists in predicting stroke risk in patients with asymptomatic carotid stenosis.
Medscape Medical News, May 22, 2008
Stenting as Effective as Endarterectomy in Treatment of Carotid Stenosis

Long-term results from 2 large European trials suggest carotid artery stenting is as effective as carotid endarterectomy in preventing recurrent ischemic stroke in patients with severe, symptomatic carotid stenosis.
Medscape Medical News, May 21, 2008
Low-Dose tPA Safe, Effective in Treating Intraventricular Hemorrhage

Treatment of intraventricular hemorrhage with catheter-based clot lysis using low-dose tissue plasminogen activator is safe and dramatically reduces death and disability in individuals with this usually lethal condition.
Medscape Medical News, May 15, 2008

Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the European Stroke Conference. These materials and the related activity are not sanctioned by the European Stroke Conference or the commercial supporter of the conference and do not constitute an official part of that conference.